{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T21:23:19Z","timestamp":1773264199987,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,10,9]],"date-time":"2017-10-09T00:00:00Z","timestamp":1507507200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00296-017-3836-9","type":"journal-article","created":{"date-parts":[[2017,10,9]],"date-time":"2017-10-09T09:37:18Z","timestamp":1507541838000},"page":"1891-1898","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Serum serotonin levels and bone in rheumatoid arthritis patients"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1849-5465","authenticated-orcid":false,"given":"Miguel","family":"Bernardes","sequence":"first","affiliation":[]},{"given":"Tiago","family":"Vieira","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Lucas","sequence":"additional","affiliation":[]},{"given":"Jorge","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"L\u00facia","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"Sim\u00f5es-Ventura","sequence":"additional","affiliation":[]},{"given":"Maria Jo\u00e3o","family":"Martins","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,10,9]]},"reference":[{"key":"3836_CR1","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jbmr.2086","volume":"29","author":"GS Lee","year":"2014","unstructured":"Lee GS, Simpson C, Sun BH, Yao C, Foer D, Sullivan B et al (2014) Measurement of plasma, serum, and platelet serotonin in individuals with high bone mass and mutations in LRP5. J Bone Miner Res 29:976\u2013981","journal-title":"J Bone Miner Res"},{"key":"3836_CR2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(01)00571-2","volume":"107","author":"Y Gong","year":"2001","unstructured":"Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM et al (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513\u2013523","journal-title":"Cell"},{"key":"3836_CR3","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa013444","volume":"346","author":"LM Boyden","year":"2002","unstructured":"Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA et al (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513\u20131521","journal-title":"N Engl J Med"},{"key":"3836_CR4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1086\/368277","volume":"72","author":"L Wesenbeeck Van","year":"2003","unstructured":"Van Wesenbeeck L, Cleiren E, Gram J, Beals RK, Benichou O, Scopelliti D et al (2003) Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet 72:763\u2013771","journal-title":"Am J Hum Genet"},{"key":"3836_CR5","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1056\/NEJM200405133502017","volume":"350","author":"MP Whyte","year":"2004","unstructured":"Whyte MP, Reinus WH, Mumm S (2004) High-bone-mass disease and LRP5. N Engl J Med 350:2096\u20132099 (author reply -9)","journal-title":"N Engl J Med"},{"key":"3836_CR6","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/jbmr.462","volume":"26","author":"D Goltzman","year":"2011","unstructured":"Goltzman D (2011) LRP5, serotonin, and bone: complexity, contradictions, and conundrums. J Bone Miner Res 26:1997\u20132001","journal-title":"J Bone Miner Res"},{"key":"3836_CR7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cell.2008.09.059","volume":"135","author":"VK Yadav","year":"2008","unstructured":"Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA, Schutz G et al (2008) Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135:825\u2013837","journal-title":"Cell"},{"key":"3836_CR8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jbmr.2059","volume":"29","author":"MK Chang","year":"2014","unstructured":"Chang MK, Kramer I, Keller H, Gooi JH, Collett C, Jenkins D et al (2014) Reversing LRP5-dependent osteoporosis and SOST deficiency-induced sclerosing bone disorders by altering WNT signaling activity. J Bone Miner Res 29:29\u201342","journal-title":"J Bone Miner Res"},{"key":"3836_CR9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-med-090710-133426","volume":"62","author":"G Karsenty","year":"2011","unstructured":"Karsenty G, Yadav VK (2011) Regulation of bone mass by serotonin: molecular biology and therapeutic implications. Annu Rev Med 62:323\u2013331","journal-title":"Annu Rev Med"},{"key":"3836_CR10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00223-010-9350-7","volume":"86","author":"VK Yadav","year":"2010","unstructured":"Yadav VK, Arantes HP, Barros ER, Lazaretti-Castro M, Ducy P (2010) Genetic analysis of Lrp5 function in osteoblast progenitors. Calcif Tissue Int 86:382\u2013388","journal-title":"Calcif Tissue Int"},{"key":"3836_CR11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.2009.03680.x","volume":"72","author":"A Saarinen","year":"2010","unstructured":"Saarinen A, Saukkonen T, Kivela T, Lahtinen U, Laine C, Somer M et al (2010) Low density lipoprotein receptor-related protein 5 (LRP5) mutations and osteoporosis, impaired glucose metabolism and hypercholesterolaemia. Clin Endocrinol 72:481\u2013488 (Oxf)","journal-title":"Clin Endocrinol"},{"key":"3836_CR12","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jbmr.44","volume":"25","author":"M Frost","year":"2010","unstructured":"Frost M, Andersen TE, Yadav V, Brixen K, Karsenty G, Kassem M (2010) Patients with high-bone-mass phenotype owing to Lrp5-T253I mutation have low plasma levels of serotonin. J Bone Miner Res 25:673\u2013675","journal-title":"J Bone Miner Res"},{"key":"3836_CR13","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/jbmr.376","volume":"26","author":"M Frost","year":"2011","unstructured":"Frost M, Andersen T, Gossiel F, Hansen S, Bollerslev J, van Hul W et al (2011) Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5. J Bone Miner Res 26:1721\u20131728","journal-title":"J Bone Miner Res"},{"key":"3836_CR14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1359\/jbmr.090721","volume":"25","author":"UI Modder","year":"2010","unstructured":"Modder UI, Achenbach SJ, Amin S, Riggs BL, Melton LJ 3rd, Khosla S (2010) Relation of serum serotonin levels to bone density and structural parameters in women. J Bone Miner Res 25:415\u2013422","journal-title":"J Bone Miner Res"},{"key":"3836_CR15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF01800371","volume":"11","author":"M Giovannini","year":"1988","unstructured":"Giovannini M, Valsasina R, Longhi R, Cesura AM, Galva MD, Riva E et al (1988) Serotonin and noradrenaline concentrations and serotonin uptake in platelets from hyperphenylalaninaemic patients. J Inherit Metab Dis 11:285\u2013290","journal-title":"J Inherit Metab Dis"},{"key":"3836_CR16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s10545-007-0462-9","volume":"30","author":"D Modan-Moses","year":"2007","unstructured":"Modan-Moses D, Vered I, Schwartz G, Anikster Y, Abraham S, Segev R et al (2007) Peak bone mass in patients with phenylketonuria. J Inherit Metab Dis 30:202\u2013208","journal-title":"J Inherit Metab Dis"},{"key":"3836_CR17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/jcb.20734","volume":"98","author":"BI Gustafsson","year":"2006","unstructured":"Gustafsson BI, Thommesen L, Stunes AK, Tommeras K, Westbroek I, Waldum HL et al (2006) Serotonin and fluoxetine modulate bone cell function in vitro. J Cell Biochem 98:139\u2013151","journal-title":"J Cell Biochem"},{"key":"3836_CR18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-5751-12-12","volume":"12","author":"C Galli","year":"2013","unstructured":"Galli C, Macaluso G, Passeri G (2013) Serotonin: a novel bone mass controller may have implications for alveolar bone. J Negat Results Biomed 12:12","journal-title":"J Negat Results Biomed"},{"key":"3836_CR19","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1210\/jc.2010-0861","volume":"95","author":"M Bliziotes","year":"2010","unstructured":"Bliziotes M (2010) Update in serotonin and bone. J Clin Endocrinol Metab 95:4124\u20134132","journal-title":"J Clin Endocrinol Metab"},{"key":"3836_CR20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1749-6632.2009.05312.x","volume":"1192","author":"VK Yadav","year":"2010","unstructured":"Yadav VK, Ducy P (2010) Lrp5 and bone formation: a serotonin-dependent pathway. Ann N Y Acad Sci 1192:103\u2013109","journal-title":"Ann N Y Acad Sci"},{"key":"3836_CR21","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1172\/JCI64906","volume":"122","author":"A Kode","year":"2012","unstructured":"Kode A, Mosialou I, Silva BC, Rached MT, Zhou B, Wang J et al (2012) FOXO1 orchestrates the bone-suppressing function of gut-derived serotonin. J Clin Invest 122:3490\u20133503","journal-title":"J Clin Invest"},{"key":"3836_CR22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1097-2765(03)00484-2","volume":"13","author":"K Tamai","year":"2004","unstructured":"Tamai K, Zeng X, Liu C, Zhang X, Harada Y, Chang Z et al (2004) A mechanism for Wnt coreceptor activation. Mol Cell 13:149\u2013156","journal-title":"Mol Cell"},{"key":"3836_CR23","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s12020-013-9962-6","volume":"44","author":"V Sibilia","year":"2013","unstructured":"Sibilia V, Pagani F, Dieci E, Mrak E, Marchese M, Zarattini G et al (2013) Dietary tryptophan manipulation reveals a central role for serotonin in the anabolic response of appendicular skeleton to physical activity in rats. Endocrine 44:790\u2013802","journal-title":"Endocrine"},{"key":"3836_CR24","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nm.2388","volume":"17","author":"Y Cui","year":"2011","unstructured":"Cui Y, Niziolek PJ, MacDonald BT, Zylstra CR, Alenina N, Robinson DR et al (2011) Lrp5 functions in bone to regulate bone mass. Nat Med 17:684\u2013691","journal-title":"Nat Med"},{"key":"3836_CR25","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1210\/jc.2012-4174","volume":"98","author":"JS Walsh","year":"2013","unstructured":"Walsh JS, Newell-Price JD, DeBono M, Adaway J, Keevil B, Eastell R (2013) Circulating serotonin and bone density, structure, and turnover in carcinoid syndrome. J Clin Endocrinol Metab 98:2902\u20132907","journal-title":"J Clin Endocrinol Metab"},{"key":"3836_CR26","doi-asserted-by":"crossref","first-page":"e109028","DOI":"10.1371\/journal.pone.0109028","volume":"9","author":"Q Wang","year":"2014","unstructured":"Wang Q, Chen D, Nicholson P, Cheng S, Alen M, Mao L et al (2014) The associations of serum serotonin with bone traits are age- and gender-specific. PLoS ONE 9:e109028","journal-title":"PLoS ONE"},{"key":"3836_CR27","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/archinte.167.2.188","volume":"167","author":"JB Richards","year":"2007","unstructured":"Richards JB, Papaioannou A, Adachi JD, Joseph L, Whitson HE, Prior JC et al (2007) Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 167:188\u2013194","journal-title":"Arch Intern Med"},{"key":"3836_CR28","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/archinte.167.12.1240","volume":"167","author":"SJ Diem","year":"2007","unstructured":"Diem SJ, Blackwell TL, Stone KL, Yaffe K, Haney EM, Bliziotes MM et al (2007) Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med 167:1240\u20131245","journal-title":"Arch Intern Med"},{"key":"3836_CR29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/YIC.0b013e3282f2b3bb","volume":"23","author":"LJ Williams","year":"2008","unstructured":"Williams LJ, Henry MJ, Berk M, Dodd S, Jacka FN, Kotowicz MA et al (2008) Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression. Int Clin Psychopharmacol 23:84\u201387","journal-title":"Int Clin Psychopharmacol"},{"key":"3836_CR30","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(97)09528-7","volume":"351","author":"B Liu","year":"1998","unstructured":"Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N (1998) Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 351:1303\u20131307","journal-title":"Lancet"},{"key":"3836_CR31","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00198-005-0065-y","volume":"17","author":"P Vestergaard","year":"2006","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2006) Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int 17:807\u2013816","journal-title":"Osteoporos Int"},{"key":"3836_CR32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/npp.1994.23","volume":"10","author":"F Karege","year":"1994","unstructured":"Karege F, Widmer J, Bovier P, Gaillard JM (1994) Platelet serotonin and plasma tryptophan in depressed patients: effect of drug treatment and clinical outcome. Neuropsychopharmacology 10:207\u2013214","journal-title":"Neuropsychopharmacology"},{"key":"3836_CR33","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1196\/annals.1432.042","volume":"1139","author":"RB Rothman","year":"2008","unstructured":"Rothman RB, Zolkowska D, Baumann MH (2008) Serotonin (5-HT) transporter ligands affect plasma 5-HT in rats. Ann N Y Acad Sci 1139:268\u2013284","journal-title":"Ann N Y Acad Sci"},{"key":"3836_CR34","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1124\/jpet.107.132654","volume":"324","author":"D Zolkowska","year":"2008","unstructured":"Zolkowska D, Baumann MH, Rothman RB (2008) Chronic fenfluramine administration increases plasma serotonin (5-hydroxytryptamine) to nontoxic levels. J Pharmacol Exp Ther 324:791\u2013797","journal-title":"J Pharmacol Exp Ther"},{"key":"3836_CR35","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nm.2098","volume":"16","author":"VK Yadav","year":"2010","unstructured":"Yadav VK, Balaji S, Suresh PS, Liu XS, Lu X, Li Z et al (2010) Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. Nat Med 16:308\u2013312","journal-title":"Nat Med"},{"key":"3836_CR36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/09629350290000069","volume":"11","author":"S Kopp","year":"2002","unstructured":"Kopp S, Alstergren P (2002) Blood serotonin and joint pain in seropositive versus seronegative rheumatoid arthritis. Mediators Inflamm 11:211\u2013217","journal-title":"Mediators Inflamm"},{"key":"3836_CR37","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/jbmr.2724","volume":"31","author":"K Klavdianou","year":"2016","unstructured":"Klavdianou K, Liossis SN, Papachristou DJ, Theocharis G, Sirinian C, Kottorou A et al (2016) Decreased serotonin levels and serotonin-mediated osteoblastic inhibitory signaling in patients with ankylosing spondylitis. J Bone Miner Res 31:630\u2013639","journal-title":"J Bone Miner Res"},{"key":"3836_CR38","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/jnci\/92.22.1801","volume":"92","author":"T Reynolds","year":"2000","unstructured":"Reynolds T (2000) Declaration of Helsinki revised. J Natl Cancer Inst 92:1801\u20131803","journal-title":"J Natl Cancer Inst"},{"key":"3836_CR39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van \u2018t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44\u201348","journal-title":"Arthritis Rheum"},{"key":"3836_CR40","doi-asserted-by":"crossref","first-page":"6509754","DOI":"10.1155\/2017\/6509754","volume":"2017","author":"M Bernardes","year":"2017","unstructured":"Bernardes M, Vieira TS, Martins MJ, Lucas R, Costa L, Pereira JG et al (2017) Myocardial Perfusion in Rheumatoid Arthritis Patients: Associations with Traditional Risk Factors and Novel Biomarkers. Biomed Res Int 2017:6509754","journal-title":"Biomed Res Int"},{"key":"3836_CR41","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1210\/jc.2011-2786","volume":"97","author":"HY Kim","year":"2012","unstructured":"Kim HY, Park MH, Yoon HK, Han KO (2012) The changes in plasma serotonin levels after hormone therapy and their relationship with estrogen responsiveness on bone in postmenopausal women. J Clin Endocrinol Metab 97:1986\u20131994","journal-title":"J Clin Endocrinol Metab"},{"key":"3836_CR42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","volume":"132","author":"MD Gershon","year":"2007","unstructured":"Gershon MD, Tack J (2007) The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132:397\u2013414","journal-title":"Gastroenterology"},{"key":"3836_CR43","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/0028-3908(84)90098-4","volume":"23","author":"JE Blundell","year":"1984","unstructured":"Blundell JE (1984) Serotonin and appetite. Neuropharmacology 23:1537\u20131551","journal-title":"Neuropharmacology"},{"issue":"Suppl","key":"3836_CR44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0195-6663(86)80051-4","volume":"7","author":"JE Blundell","year":"1986","unstructured":"Blundell JE (1986) Serotonin manipulations and the structure of feeding behaviour. Appetite 7(Suppl):39\u201356","journal-title":"Appetite"},{"key":"3836_CR45","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1749-6632.1990.tb16907.x","volume":"600","author":"G Curzon","year":"1990","unstructured":"Curzon G (1990) Serotonin and appetite. Ann N Y Acad Sci 600:521\u2013530 (discussion 30-1)","journal-title":"Ann N Y Acad Sci"},{"key":"3836_CR46","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0091-3057(90)90556-W","volume":"37","author":"SF Leibowitz","year":"1990","unstructured":"Leibowitz SF, Weiss GF, Suh JS (1990) Medial hypothalamic nuclei mediate serotonin\u2019s inhibitory effect on feeding behavior. Pharmacol Biochem Behav 37:735\u2013742","journal-title":"Pharmacol Biochem Behav"},{"key":"3836_CR47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0166-4328(96)00066-6","volume":"73","author":"KJ Simansky","year":"1996","unstructured":"Simansky KJ (1996) Serotonergic control of the organization of feeding and satiety. Behav Brain Res 73:37\u201342","journal-title":"Behav Brain Res"},{"key":"3836_CR48","first-page":"361","volume":"14","author":"J McGuirk","year":"1990","unstructured":"McGuirk J, Silverstone T (1990) The effect of the 5-HT re-uptake inhibitor fluoxetine on food intake and body weight in healthy male subjects. Int J Obes 14:361\u2013372","journal-title":"Int J Obes"},{"key":"3836_CR49","first-page":"237","volume":"15","author":"H Pijl","year":"1991","unstructured":"Pijl H, Koppeschaar HP, Willekens FL, Op de Kamp I, Veldhuis HD, Meinders AE (1991) Effect of serotonin re-uptake inhibition by fluoxetine on body weight and spontaneous food choice in obesity. Int J Obes 15:237\u2013242","journal-title":"Int J Obes"},{"key":"3836_CR50","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/j.1550-8528.1995.tb00160.x","volume":"3","author":"CL Lawton","year":"1995","unstructured":"Lawton CL, Wales JK, Hill AJ, Blundell JE (1995) Serotoninergic manipulation, meal-induced satiety and eating pattern: effect of fluoxetine in obese female subjects. Obes Res 3:345\u2013356","journal-title":"Obes Res"},{"key":"3836_CR51","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0031-9384(99)00020-7","volume":"66","author":"AS Ward","year":"1999","unstructured":"Ward AS, Comer SD, Haney M, Fischman MW, Foltin RW (1999) Fluoxetine-maintained obese humans: effect on food intake and body weight. Physiol Behav 66:815\u2013821","journal-title":"Physiol Behav"},{"key":"3836_CR52","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/0091-3057(79)90075-3","volume":"10","author":"RG MacKenzie","year":"1979","unstructured":"MacKenzie RG, Hoebel BG, Ducret RP, Trulson ME (1979) Hyperphagia following intraventricular p-chlorophenylalanine-, leucine- or tryptophan-methyl esters: lack of correlation with whole brain serotonin levels. Pharmacol Biochem Behav 10:951\u2013955","journal-title":"Pharmacol Biochem Behav"},{"key":"3836_CR53","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1359\/JBMR.040606","volume":"19","author":"R Battaglino","year":"2004","unstructured":"Battaglino R, Fu J, Spate U, Ersoy U, Joe M, Sedaghat L et al (2004) Serotonin regulates osteoclast differentiation through its transporter. J Bone Miner Res 19:1420\u20131431","journal-title":"J Bone Miner Res"},{"key":"3836_CR54","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bone.2011.04.015","volume":"49","author":"UI Modder","year":"2011","unstructured":"Modder UI, Roforth MM, Hoey K, McCready LK, Peterson JM, Monroe DG et al (2011) Effects of estrogen on osteoprogenitor cells and cytokines\/bone-regulatory factors in postmenopausal women. Bone 49:202\u2013207","journal-title":"Bone"},{"key":"3836_CR55","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jcp.21533","volume":"217","author":"C Jonnakuty","year":"2008","unstructured":"Jonnakuty C, Gragnoli C (2008) What do we know about serotonin? J Cell Physiol 217:301\u2013306","journal-title":"J Cell Physiol"},{"key":"3836_CR56","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.clinbiochem.2003.11.009","volume":"37","author":"Y Hirowatari","year":"2004","unstructured":"Hirowatari Y, Hara K, Kamihata H, Iwasaka T, Takahashi H (2004) High-performance liquid chromatographic method with column-switching and post-column reaction for determination of serotonin levels in platelet-poor plasma. Clin Biochem 37:191\u2013197","journal-title":"Clin Biochem"},{"key":"3836_CR57","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/clinchem\/42.7.1086","volume":"42","author":"E Pussard","year":"1996","unstructured":"Pussard E, Guigueno N, Adam O, Giudicelli JF (1996) Validation of HPLC-amperometric detection to measure serotonin in plasma, platelets, whole blood, and urine. Clin Chem 42:1086\u20131091","journal-title":"Clin Chem"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-017-3836-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3836-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3836-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T22:52:15Z","timestamp":1603061535000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-017-3836-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,9]]},"references-count":57,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["3836"],"URL":"https:\/\/doi.org\/10.1007\/s00296-017-3836-9","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,9]]}}}